Author:
Dagli Necati,Yavuzkir Mustafa,Karaca Ilgin
Publisher
Springer Science and Business Media LLC
Subject
Immunology,Immunology and Allergy
Reference35 articles.
1. Murray, C. J., and A. D. Lopez. 1997. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet. 349:1269–1276.
2. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. 2001. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 285:2486–2497.
3. Kastelein, J., and M. J. van Dam. 2001. A new role for combination therapy in lipid management. Br. J. Cardiol. 8:639–653.
4. Pearson, T. A., I. Laurora, H. Chu, and S. Kafonek. 2000. The lipid treatment assessment project (L–TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals. Arch. Intern. Med. 28(160):459–467.
5. van Heek, M, C. F. France, D. S. Compton, R. L. Mcleod, N. P. Yumibe, K. B. Alton, E. J. Sybertz, and H. R. Davis, Jr. 1997. In vivo metabolism-based discovery of a potent cholesterol absorption inhibitor, SCH58235, in the rat and rhesus monkey through the identification of the active metabolites of SCH48461. J. Pharmacol. Exp. Ther. 283:157–163.